AUTHOR

Louise Mckinlay

https://www.msnz.org.nz

POSTS

ECTRIMS 2022 Conference

December 6, 2022 | Education, Event, Research

The 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) took place in Amsterdam from 26th to 28th October, and was attended by Dr. John. Mottershead online. The programme included Scientific Sessions, Hot Topics and […]


Update: Siponimod (Mayzent) for Secondary Progressive MS

November 16, 2022 | Advocacy, Funding, Treatments

At the August 2022 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC), Multiple Sclerosis NZ (MSNZ) made a submission in support of the funding of Siponimod (Mayzent) for Secondary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested further advice from the […]


Accessibility for New Zealanders Bill Submission

November 16, 2022 | Advocacy, Life with MS, Media

Recently, MSNZ made a submission to the Accessibility for New Zealanders Bill. The intention of the proposed bill is to establish “a new legislative framework that addresses systemic accessibility barriers that prevent disabled people, tāngata whaikaha and their whānau, and […]


Malcolm Rickerby: Honorary Life Member

November 9, 2022 | Uncategorised

Malcolm Rickerby is what can only be described as the ultimate volunteer. The countless hours and passion he has dedicated to Multiple Sclerosis New Zealand since the 1970s has not been matched by any other in recent memory. Malcolm has […]


Submission to Select Health Committee to make aHSCT available in New Zealand

November 9, 2022 | Advocacy, Media

This morning, 9th November 2022,  MSNZs President, Neil Woodhams and petition submitter, Joan Perry made an oral presentation to the Health Select Committee calling for them to make aHSCT an available treatment option in NZ. It was live streamed on […]